山东药玻：公司前三季度利润下滑主要原因是国内受医药行业集采政策深化和医保支付改革等影响

Core Viewpoint - The company's profit decline in the third quarter is primarily attributed to the weakening demand in the pharmaceutical packaging materials market, influenced by the deepening of domestic drug procurement policies and healthcare payment reforms [1] Company Summary - The company reported a profit decline in the first three quarters of the year [1] - The main reason for the profit decline is the impact of domestic drug procurement policies and healthcare payment reforms on market demand [1] Industry Summary - The pharmaceutical packaging materials market is experiencing reduced demand due to regulatory changes in the industry [1]